← Back to the blog

IBO Advisors Insights

Management Buyout vs Private Equity: Price, Leadership, and When You Actually Get Paid

Two deal structures set side by side and compared on a tablet at a mountain summit

A private equity firm almost always pays a higher headline price and puts more cash on the closing table. A management buyout almost always leaves you financing a large part of your own sale and waiting years to collect it. Retaining leadership after closing runs the other way. The deciding number is not the multiple - it is how much of the price you hold in cash the day you sign.

What each one actually is

A management buyout is a sale to the people already running your company, funded by a bank loan against the company's assets, a modest slug of the team's personal savings, and a seller note you write yourself. The mechanics are in management buyout financing; the short version is that management rarely brings enough capital to buy you out, so the gap lands on you.

A private equity buyout is a sale to a fund whose business is buying control of companies, holding them for a defined period, and selling them again. What a private equity buyout is and how it works sets out the variants an owner at this size will actually meet — a fund platform deal, a secondary sale from one fund to another, or an add-on into a company a fund already owns — and how private equity actually finances a buyout walks through that capital stack line by line. The fund rarely buys all of it: the standard offer at this size is a majority recapitalization that takes 51-80% and asks you to roll the remainder.

They are not mutually exclusive. CT Acquisitions' 2026 structural guide puts MBOs at roughly 14 percent of US lower-middle-market deal volume in 2025, while 41 percent of sub-$100 million transactions involved some form of management participation - meaning most "management buyouts" at this size are really sponsor deals with management riding along.

MBO, MBI, LBO: how the buyout labels differ

Owners comparing offers run into four or five words that sound like alternatives to each other and are not. The most common confusion is "leveraged buyout versus management buyout", and it is a category error. A leveraged buyout is not a type of buyer. It is a way of paying: a purchase funded mostly with debt borrowed against the company being bought, serviced out of that company's own cash flow. A private equity deal is almost always an LBO. A bank-financed management buyout is also an LBO. So is an Independent Buyout. The label tells you where the money came from, not who ends up owning the business.

These are the distinctions that actually change the deal in front of you. The full list, including the structures that do not involve selling control at all, is in the seven types of buyouts.

Term Who the buyer is What it means for you
Leveraged buyout (LBO) Anyone - it describes the financing, not the buyer Your company carries the debt that bought it, whoever the buyer is
Management buyout (MBO) The team already running the company Continuity, a lower multiple, and usually a seller note you carry
Management buy-in (MBI) An outside manager or team that installs itself at the top No continuity premium - your incumbent managers are the ones being replaced
BIMBO Incumbent managers plus an incoming executive, together Often used when the team is strong operationally but has no CEO-in-waiting
Private equity buyout A fund buying control, with a defined hold and exit Highest cash at close, and governance moves to the sponsor
Secondary buyout One sponsor selling to another sponsor Only relevant to you later - it is how your rollover equity eventually pays out
Employee buyout (ESOP) A trust holding the company on behalf of its employees Bank debt and seller notes do the work, and a qualifying sale can be structured for deferral
Independent Buyout (IBO) A trust for the company’s own employees, with the leadership already in place continuing to run it Sponsor-level leverage and pricing, with no fund on the cap table and no exit clock

Two of these carry consequences owners underrate. An MBI is sold as "a buyout by management", but the managers are not yours - the incoming team's first job is usually to restructure the one you built, so the cultural argument for an internal sale does not apply. And a secondary buyout is the back half of the sponsor route: if you roll equity into a fund's deal, the event that turns that paper into money is frequently a sale to the next fund rather than to a strategic acquirer, which is one reason the second bite arrives later and smaller than owners expect.

The practical test is simpler than the vocabulary. Ask who signs the purchase agreement, where their money comes from, and who holds the board the following Monday. Those three answers sort every structure above, and they are the same three questions behind what a private equity buyout looks like from the inside once the wire clears.

Price: what each buyer type pays

The gap is consistent and it is large. Management buyouts in the lower middle market clear at 4x to 6x trailing EBITDA for most industries - roughly 1x to 2x below a strategic acquirer. Private equity platform pricing over the same period, per GF Data's contributed deal set, ran 6.4x for $10-25 million enterprise values, 6.8x for $25-50 million, and 8.3x for $50-100 million in the first nine months of 2025.

There is no mystery about why. Management is negotiating against an owner they report to, with information nobody else in the process has, spending money they mostly do not have. A sponsor is competing against other sponsors, using a fund that is paid to deploy capital. Chambers and Partners states it plainly: "An MBO sale can deliver a lower headline price."

Before you weigh either offer, get your own range. How PE firms value a company explains the adjustments a buyer will make to your EBITDA, and the business valuation calculator will give you a defensible starting number.

The arithmetic on a $6 million EBITDA company

Take an invented company - $6,000,000 of adjusted EBITDA, no real-world counterpart - and price it both ways using the ranges above.

The management buyout. At 5.0x, enterprise value is $30,000,000. Senior lenders here underwrite 3.0x to 5.0x trailing EBITDA, averaging 3.8x; an MBO sits at the conservative end, so call it 3.0x, or $18,000,000. The team puts in $1,500,000 of personal capital. That leaves $10,500,000 - 35 percent of the price - as a seller note you hold at a 5 to 8 percent coupon over three to seven years. Seller financing shows up on 62 percent of surveyed lower-middle-market buyouts, with the owner taking 60 to 75 percent of enterprise value in cash at close.

The private equity deal. At 6.8x, enterprise value is $40,800,000. Senior debt at 3.8x is $22,800,000. The sponsor asks you to roll 20 percent of your proceeds - $8,160,000 - and funds the remaining $9,840,000 from the fund. You take $32,640,000 in cash at closing. Structured this way the deal is a majority recapitalization, and the rolled slice is worth a smaller share of the business than the percentage suggests once the debt is counted.

Management buyout Private equity buyout
Multiple 5.0x 6.8x
Enterprise value $30,000,000 $40,800,000
Senior debt $18,000,000 $22,800,000
Buyer equity $1,500,000 (management savings) $9,840,000 (fund)
Seller note you carry $10,500,000 —
Equity you roll — $8,160,000
Cash to you at closing $19,500,000 $32,640,000

A $10,800,000 gap in headline price becomes a $13,140,000 gap in cash at the closing table. That is the number owners almost never see until a term sheet is in front of them, because the conversation up to that point is conducted entirely in multiples.

What happens to the money you did not collect

Your $10,500,000 seller note is a loan to your own buyer, almost always subordinated to the $18,000,000 the bank lent. If the business stumbles after you hand over the keys, the bank gets paid and you wait. The coupon - say 7 percent, or $735,000 a year at the start - is interest income taxed at ordinary rates, not capital gains. And the performance risk is yours twice over: you are a creditor of the business you just sold, ranked behind the bank, with no vote on how it is run.

Your $8,160,000 of rollover equity is a different animal. It is not debt, it has no coupon, and it converts to cash only when the sponsor sells - the "second bite of the apple". That wait is lengthening. Bain & Company's 2026 outlook reports that "holding periods at exit are hovering around seven years, up from an average of five to six years from 2010 to 2021", against a backlog of "roughly 32,000 companies representing a stunning $3.8 trillion in value". Distributions as a share of net asset value sat at 14 percent, a level Bain notes has not been seen since 2008-09.

Neither instrument is bad. Both are illiquid, and neither belongs in the column you file under "what I got for the company".

The tax bill arrives on a different schedule too

Cash at closing is taxed the year you receive it. The part you did not collect is taxed on whatever schedule the instrument dictates, and the two structures above pick different schedules.

A seller note makes you an installment seller. An installment sale is "a disposition of property where at least 1 payment is to be received after the close of the taxable year in which the disposition occurs", and under the installment method of 26 U.S. Code § 453 you recognize gain as "that proportion of the payments received in that year which the gross profit... bears to the total contract price". Spreading the gain is usually the point. What catches owners is the surcharge attached to it.

Under 26 U.S. Code § 453A, once the sales price exceeds $150,000 and "the face amount of all such obligations held by the taxpayer which arose during, and are outstanding as of the close of, such taxable year exceeds $5,000,000", you owe annual interest to the government on the tax you have deferred. The charge is the "applicable percentage" of the deferred tax liability multiplied by the underpayment rate under § 6621(a)(2) - and the applicable percentage is the share of the note sitting above the $5,000,000 line.

Run it on the $10,500,000 note from the example, assuming a near-zero basis in founder stock and a 20 percent long-term capital gains rate:

  • Applicable percentage: ($10,500,000 − $5,000,000) ÷ $10,500,000 = 52.4%
  • Deferred tax liability: $10,500,000 of unrecognized gain × 20% = $2,100,000
  • Interest charge at the 7% underpayment rate the IRS set for the quarter beginning October 1, 2026 (IRS, fourth quarter 2026 rates): 52.4% × $2,100,000 × 7% = about $77,000 in the first year alone

That is before the coupon. The roughly $735,000 of annual interest the buyer pays you is ordinary income, not capital gain, so it is taxed at a materially higher rate than the principal underneath it. Net it out and a seller note is a deferral you rent rather than a deferral you receive.

Rollover equity in a sponsor deal is usually structured so the rolled portion is not a taxable event at closing - you are exchanging shares, not collecting cash - which means no installment interest charge and no ordinary-income coupon, but also no cash until the sponsor sells. Whether a particular rollover qualifies turns on how the new holding company is formed, which is a question for your tax counsel before the term sheet is signed, not after.

Retaining leadership after closing

This is where the MBO wins, and it is not close. The people running the company on Monday are the people who ran it on Friday. No new board, no investment committee, no consent list. The constraint is the bank's loan covenants, which are real but narrow.

A sponsor buys governance along with the equity. Even a minority position typically comes with board seats and a schedule of veto rights over budgets, hires, debt, and any sale. Chambers notes that private equity buyers "are typically looking for growth over a defined period (often 3 to 5 years)" and will want the founder or senior management to stay through it. The year-by-year arc of a private equity buyout runs from the first hundred days - reporting cadence, value-creation plan, a CFO with two bosses - through to an exit the fund, not you, decides to call.

The conflict nobody names in an MBO

There is a structural problem in a management buyout that no amount of goodwill fixes. The buyers are your fiduciaries. They know your customer concentration, your pending renewals, and which line of the forecast is soft - and every dollar they do not pay you is a dollar of their own return. That is arithmetic, not bad faith, and it is why public-company boards facing a management bid hand the negotiation to a special committee of independent directors with its own valuation and counsel.

Private companies rarely have independent directors to appoint, which makes your own representation the only check in the room. Goodwin's guidance to management teams makes the point from the other side, advising that "engaging separate legal representation can help ensure that the unique interests of management members are adequately protected". If your CFO has separate counsel and you do not, you are the only unrepresented party at your own sale; choosing an M&A advisory firm covers what to ask before you hire one.

Process risk compounds it. Retrading - the buyer lowering the price during or after diligence - hits roughly 30 to 40 percent of lower-middle-market buyouts, and a well-run MBO takes six to nine months. A team that cannot raise its piece at month seven leaves you with a stale process and a leadership group that knows exactly what you were willing to accept.

Side by side

Dimension Management buyout Private equity buyout
Typical LMM multiple 4x-6x EBITDA 6.4x-8.3x by size tier (GF Data, 9M 2025)
Cash at closing 60-75% of enterprise value Higher, less rollover
What you carry afterward Subordinated seller note, 3-7 years Rollover equity, liquid only at the sponsor's exit
Governance after closing Unchanged; bank covenants only Board seats, consent rights, value-creation plan
Who funds it Bank + management savings + you Bank + committed fund capital
Certainty of funds Depends on the team's borrowing capacity Generally high once a sponsor is under LOI
Time to close 6-9 months Comparable, with more process discipline
Your negotiating counterparty Your own fiduciaries An arm's-length professional buyer

Where the Independent Buyout sits

The comparison above has an obvious shape: the MBO gives you continuity and a smaller, slower check; the sponsor gives you a bigger, faster check and a new boss. An Independent Buyout is built to take the left column's governance and the right column's financing capacity.

The purchase is financed by borrowing against the company through a trust structure - sized off cash flow, the way a sponsor sizes a leveraged buyout, rather than off whatever the management team can pull from a home equity line. Existing leadership keeps running the business, with no financial sponsor on the board and no exit clock, and the proceeds do not depend on a large seller note to close the gap.

Depending on the facts, a qualifying sale can also defer capital gains under 26 U.S. Code § 1042, which lets a seller of qualified securities recognize gain "only to the extent that the amount realized on such sale exceeds the cost to the taxpayer of such qualified replacement property", provided the buying entity holds at least 30 percent of the stock immediately after the sale and the proceeds are reinvested within the statutory replacement period. A conventional MBO stock sale has no equivalent deferral. Confirm your own eligibility with a tax advisor - this is fact-specific, not a blanket promise.

If the buyers you have in mind are your children rather than your executives, the same funding question applies and family business succession planning takes it from there. If you have not yet narrowed the field to two options, business exit planning: every option lays out the full set.

Frequently asked questions

Does a management buyout always pay less than private equity? Not always, but the market data says usually. MBOs in the lower middle market cluster at 4x-6x EBITDA against sponsor platform pricing of 6.4x-8.3x depending on size. The gap widens further once you compare cash at closing rather than headline enterprise value.

Can I run both processes at the same time? Yes, and many owners do, but tell your management team before you start. Once the team knows a sponsor process is running they will price their own bid against it, and once a sponsor knows management wants to buy the company, it will factor that into retention terms.

What is the difference between a leveraged buyout and a management buyout? They answer different questions. A leveraged buyout describes how a purchase is paid for - mostly with debt borrowed against the company being acquired. A management buyout describes who is buying: the incumbent team. Most management buyouts are leveraged buyouts, and so are most private equity deals; the leverage tells you nothing about who will own the company afterward.

Is rollover equity safer than a seller note? They fail differently. A seller note has a contractual coupon and maturity but sits behind the bank if things go wrong. Rollover equity has no maturity at all and pays only when the sponsor exits - around seven years, on current holding periods.

What if my management team cannot raise the money? That is the common outcome, and it is why most lower-middle-market "management buyouts" end up sponsor-financed with the team taking a minority stake. Ask for proof of financing before you grant exclusivity, not after.

Sources

The bottom line

Compare the two on cash at closing, not on the multiple. On the invented company above, a 1.8-turn difference in multiple became a $13,140,000 difference in what hits your account the day you sign - and the balance sits either behind a bank as a subordinated note or inside a fund for seven years. Continuity is worth paying for, but you should know the price, and that is the conversation the industry consistently fails to have with owners.

If your company does $3M+ in EBITDA and you are weighing a management buyout against a sponsor process, talk to IBO Advisors about how an Independent Buyout prices against both.

Curious whether an Independent Buyout fits your business?

Learn More